Viewing Study NCT03387592


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2026-02-04 @ 2:51 AM
Study NCT ID: NCT03387592
Status: TERMINATED
Last Update Posted: 2025-03-10
First Post: 2017-12-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroendocrine Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neuroendocrine Carcinoma View
None second line therapy View
None PET imaging View
None FOLFIRI View
None CAPTEM View